Sentence examples for develop an hiv from inspiring English sources

Privail, a second student-led startup co-founded by Ategeka, is also working to develop an HIV early-detection kit that could be deployed across AIDS-ravaged Africa. AIDS-ravaged Africa

Despite numerous attempts over many years to develop an HIV vaccine based on classical strategies, none has convincingly succeeded to date.

The Schools of Nursing at Muhimbili University of Health and Allied Sciences and the University of California, San Francisco (UCSF) have been collaborating on a twinning partnership to develop an HIV nursing education preservice curriculum.

Her recent study findings on the value of integrating HIV testing in substance use treatment programs were the basis for the Substance Abuse Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse NIDAA) to develop an HIV awareness toolkit for substance use treatment providers.

Another proposal is to allow companies that agree to develop an HIV vaccine a limited extension to their patents on blockbuster drugs in their most lucrative markets.A different approach, being championed by MSF, is to make a virtue of the rarity of tropical diseases in the West.

Recent progress in the identification and characterization of such antibodies, as well as advances in designing candidates that stimulate cellular immunity and results from recent clinical trials are fueling efforts to develop an HIV vaccine that could vanquish the virus once and for all.

The identification of HIV epitopes that represent a large proportion of the circulating virus population must be included to develop a HIV vaccine that can stimulate a robust immune response.

There has consequently been continued effort to develop a HIV vaccine with a MPER immunogen.

Now he believes he's close to developing an HIV vaccine based on this form of natural immunity.

Up Broadway Street, there are a few other Y Combinator startups like journalism crowdfunding platform Beacon Reader and The Immunity Project, which is developing an HIV and AIDS vaccine.

Compared to HCV, Gilead has perhaps less competition in HIV, and the market is not dwindling, and developing an HIV vaccine is more difficult because the virus keeps on evolving (but read today's Time magazine report on PrEP, an HIV prevention drug).